COMMUNIQUÉS West-GlobeNewswire

-
Intrommune Therapeutics Announces Independent Editorial Highlighting Breakthrough Safety Data for Novel Toothpaste Peanut Allergy Treatment
28/05/2025 -
AI GPO Launches as Nation’s First AI-Focused Group Purchasing Organization, Democratizing Advanced AI Technology and Essential Business Savings
28/05/2025 -
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
28/05/2025 -
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
28/05/2025 -
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
28/05/2025 -
PacBio to Present at Upcoming Investor Conferences
28/05/2025 -
Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040
28/05/2025 -
Olympia Pharmaceuticals Secures $637,000 Workforce Training Grant to Boost Job Creation in Orlando
28/05/2025 -
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
28/05/2025 -
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
28/05/2025 -
HCVC leads kyron.bio €5.5M round to use glycan engineering for advanced drug design
28/05/2025 -
Alpha Tau to Present at Jefferies Global Healthcare Conference
28/05/2025 -
iTeos Therapeutics Announces Its Intention to Wind Down Operations
28/05/2025 -
Vittoria Biotherapeutics to Share Trials-in-Progress Presentation from Phase 1 Study of VIPER-101 at ASCO 2025 Annual Meeting
28/05/2025 -
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
28/05/2025 -
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
28/05/2025 -
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
28/05/2025 -
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
28/05/2025 -
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
28/05/2025
Pages